| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | nuclear speck | BARD1 E2F7 UBASH3A YTHDC1 NCAPG2 NSRP1 TCERG1 MBD4 NXF1 DYRK3 THOC1 DOCK1 NRDE2 PRPF40A NAMPT TENM1 | 9.57e-06 | 431 | 213 | 16 | GO:0016607 |
| GeneOntologyCellularComponent | centriole | KIAA0586 TSSK2 CNTLN CEP350 CEP170 ODF2L CEP120 IFT81 STIL TUBD1 | 1.11e-05 | 172 | 213 | 10 | GO:0005814 |
| GeneOntologyCellularComponent | microtubule organizing center | KIAA0586 TSSK2 CNTLN SFR1 TRIP4 CEP350 CEP170 ODF2L CEP120 ASPM GNAI2 DYRK3 IFT81 DYNC2I1 STIL ARHGAP35 LATS1 TTLL6 CCNB2 ERCC6L2 TTC39A TUBD1 | 1.85e-04 | 919 | 213 | 22 | GO:0005815 |
| Domain | RNaseH-like_dom | 1.35e-05 | 69 | 213 | 7 | IPR012337 | |
| Domain | FF_domain | 2.85e-05 | 6 | 213 | 3 | IPR002713 | |
| Domain | FF | 2.85e-05 | 6 | 213 | 3 | PS51676 | |
| Domain | FF | 2.85e-05 | 6 | 213 | 3 | PF01846 | |
| Domain | FF | 2.85e-05 | 6 | 213 | 3 | SM00441 | |
| Domain | DNA_polymerase_A | 1.29e-04 | 2 | 213 | 2 | IPR002298 | |
| Domain | DHR-1_domain | 2.26e-04 | 11 | 213 | 3 | IPR027007 | |
| Domain | DHR_2 | 2.26e-04 | 11 | 213 | 3 | PS51651 | |
| Domain | DHR_1 | 2.26e-04 | 11 | 213 | 3 | PS51650 | |
| Domain | DHR-2 | 2.26e-04 | 11 | 213 | 3 | PF06920 | |
| Domain | DOCK | 2.26e-04 | 11 | 213 | 3 | IPR026791 | |
| Domain | Synaptobrevin | 2.26e-04 | 11 | 213 | 3 | PF00957 | |
| Domain | DOCK_C | 2.26e-04 | 11 | 213 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 2.26e-04 | 11 | 213 | 3 | PF14429 | |
| Domain | DHR-2 | 2.26e-04 | 11 | 213 | 3 | IPR027357 | |
| Domain | V_SNARE | 2.98e-04 | 12 | 213 | 3 | PS50892 | |
| Domain | Synaptobrevin | 3.84e-04 | 13 | 213 | 3 | IPR001388 | |
| Domain | DNA_pol_A | 3.85e-04 | 3 | 213 | 2 | PF00476 | |
| Domain | DNA-dir_DNA_pol_A_palm_dom | 3.85e-04 | 3 | 213 | 2 | IPR001098 | |
| Domain | DNA_POLYMERASE_A | 3.85e-04 | 3 | 213 | 2 | PS00447 | |
| Domain | POLAc | 3.85e-04 | 3 | 213 | 2 | SM00482 | |
| Domain | - | 7.65e-04 | 4 | 213 | 2 | 1.10.10.440 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK17 GAPVD1 DOCK11 IQSEC2 TSSK2 CEP350 CDR2L CEP170 TCERG1 NAA15 FAM98A STIL E2F8 LATS1 ANKRD11 AKAP13 LIMCH1 R3HDM1 TSSK1B FGD6 DOP1A | 1.61e-07 | 861 | 220 | 21 | 36931259 |
| Pubmed | GAPVD1 IQSEC2 PSMC2 CEP350 JAK1 CEP120 MBD4 DMXL2 SEC31A ARHGAP35 NCAPH DIS3 CUL5 MRPL4 TMOD1 AKAP13 FGD6 RPAP2 | 4.81e-07 | 689 | 220 | 18 | 36543142 | |
| Pubmed | SPCS2 PSMC2 TRIP4 NSRP1 KNOP1 LARP4B TAF9 FAM135A GOLGA3 NXF1 DNAJC16 SEC22B FAM98A SEC31A SIL1 OSBP LATS1 CCNB2 TMEM131 EIF3B R3HDM1 RPAP2 | 5.20e-07 | 1007 | 220 | 22 | 34597346 | |
| Pubmed | KIAA0586 YTHDC1 CASZ1 CEP350 CEP170 LARP4B FAT2 FAM135A DMXL2 LRRN1 ARHGAP35 UBR3 TTC39A FGD6 DOP1A | 6.87e-07 | 493 | 220 | 15 | 15368895 | |
| Pubmed | ATR NCAPG2 TCERG1 WASHC5 CARD6 NXF1 FNDC3B NRDE2 DMXL2 RIOK1 NAA15 DNAJC16 DIS3 CUL5 NAMPT AKAP13 ELP2 | 9.95e-07 | 650 | 220 | 17 | 38777146 | |
| Pubmed | GALNT3 YTHDC1 TRIP4 CASZ1 HMG20A KNOP1 LARP4B DIMT1 TCERG1 EIF3L TAF9 MBD4 NXF1 CNP FNDC3B NRDE2 DNAJC16 PHRF1 FAM98A ZNF800 TMEM120A BAZ1A SMARCA2 ANKRD11 LIMCH1 EIF3B CBX8 | 1.06e-06 | 1497 | 220 | 27 | 31527615 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ZGRF1 E2F7 CNTLN ODF2L TCERG1 ASPM TAF9 FAM135A NXF1 WASHC2C DIS3 ZZZ3 CCNB2 SENP6 CFAP44 RPAP2 | 1.25e-06 | 588 | 220 | 16 | 38580884 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CDK17 GAPVD1 TUBA3E CEP350 CEP170 ODF2L CEP120 WASHC5 EIF3L ASPM GNAI2 NXF1 NAA15 WASHC2C CTC1 TTC27 DYNC2I1 CCNB2 SMARCA2 SMARCD1 EIF3B ZMYM1 LRRFIP2 | 1.38e-06 | 1155 | 220 | 23 | 20360068 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PSMC2 PGD NCAPG2 DIMT1 TCERG1 WASHC5 EIF3L ASPM GNAI2 NXF1 CNP FNDC3B NAA15 POLD2 TTC27 SEC22B FAM98A SEC31A NCAPH DIS3 NAMPT BAZ1A SMARCA2 AKAP13 EIF3B | 1.79e-06 | 1353 | 220 | 25 | 29467282 |
| Pubmed | 2.01e-06 | 15 | 220 | 4 | 19762545 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | DOCK11 TRIP4 CEP350 CEP170 LARP4B NXF1 CNP THOC1 FNDC3B NRDE2 FAM98A SEC31A ARHGAP35 AKAP13 TMEM131 ZMYM1 R3HDM1 | 4.22e-06 | 724 | 220 | 17 | 36232890 |
| Pubmed | 4.92e-06 | 6 | 220 | 3 | 16791115 | ||
| Pubmed | GAPVD1 BRIP1 TRIP4 CEP350 CEP170 LARP4B EIF3L RIOK1 DNAJC16 DYNC2I1 FNDC3A YKT6 AKAP13 TMEM131 ZMYM1 R3HDM1 RPAP2 | 4.96e-06 | 733 | 220 | 17 | 34672954 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | TRIP4 CEP350 CEP170 LARP4B EIF3L GOLGA3 TTC27 FAM98A SIL1 LATS1 TMOD1 LIMCH1 EIF3B ZMYM1 R3HDM1 CBX8 LRRFIP2 | 7.17e-06 | 754 | 220 | 17 | 33060197 |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | GAPVD1 IQSEC2 E2F7 NSRP1 ODF2L STX1A VAMP1 GNAI2 PIGB FAM210A DOCK9 SEC31A MRPL4 BAZ1A TMOD1 LIMCH1 EIF3B ZMYM1 TUBD1 | 7.73e-06 | 925 | 220 | 19 | 28986522 |
| Pubmed | MYT1L IQSEC2 UBASH3A HMG20A CEP350 JAK1 ODF2L STX1A TCERG1 MBD4 GOLGA3 NR1D2 AKAP6 DMXL2 IFT81 TTC27 DYNC2I1 CRTAC1 SEC31A SENP6 TMEM131 R3HDM1 LGI1 | 7.98e-06 | 1285 | 220 | 23 | 35914814 | |
| Pubmed | ATR YTHDC1 PGD HMG20A TCERG1 EIF3L TAF9 MBD4 NXF1 THOC1 POLD2 NCAPH PRPF40A DIS3 CUL5 NAMPT BAZ1A SMARCA2 SMARCD1 EIF3B | 8.01e-06 | 1014 | 220 | 20 | 32416067 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | CDK17 ATR RYR2 LARP4B ASPM PURG DOCK1 CTC1 DNAJC16 FAM98A MRPL4 TMEM131 ELP2 | 8.92e-06 | 462 | 220 | 13 | 31138677 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABCC4 BARD1 COG3 KCNIP3 NSRP1 CASZ1 CEP170 ODF2L ERI3 DOCK1 LRRN1 RASA1 FRMPD2 DYNC2I1 ARHGAP35 CERT1 SIL1 CUL5 SMARCA2 ANKRD11 RASEF AKAP13 LIMCH1 DOP1A RPAP2 | 9.45e-06 | 1489 | 220 | 25 | 28611215 |
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | GAPVD1 COG3 KCNIP3 JAK1 ALKBH8 DIMT1 FAM200B CD4 ANKRD30A FGD6 | 1.02e-05 | 272 | 220 | 10 | 18187620 |
| Pubmed | Gene essentiality and synthetic lethality in haploid human cells. | PSMC2 COG3 EIF3L FAM210A TTC27 CERT1 PRPF40A ANKRD11 TMEM131 | 1.69e-05 | 229 | 220 | 9 | 26472760 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | GAPVD1 DOCK11 GC PTPN22 AK9 NEB RIOK1 DOCK9 IFT81 SLITRK4 ERCC6L2 ANKRD11 LIMCH1 | 1.92e-05 | 497 | 220 | 13 | 36774506 |
| Pubmed | 2.04e-05 | 9 | 220 | 3 | 26926046 | ||
| Pubmed | 2.04e-05 | 9 | 220 | 3 | 26269593 | ||
| Pubmed | MYT1L GAPVD1 SPCS2 KNOP1 LARP4B ALKBH8 FAM135A AKAP6 NRDE2 WASHC2C CTC1 FAM210A POLD2 DOCK9 SEC31A DIS3 E2F8 BAZ1A TMEM131 ZMYM1 | 2.09e-05 | 1084 | 220 | 20 | 11544199 | |
| Pubmed | ABCC4 COG3 WASHC5 FAM135A GOLGA3 DMXL2 WASHC2C DNAJC16 FNDC3A SEC22B YKT6 TENM1 TMEM131 | 2.22e-05 | 504 | 220 | 13 | 34432599 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ATR SPCS2 BARD1 YTHDC1 CASZ1 HMG20A KNOP1 ZSCAN29 TCERG1 TAF9 MBD4 NXF1 THOC1 PHRF1 SEC22B PRPF40A ZZZ3 BAZ1A CCNB2 ANKRD11 JRKL CBX8 | 2.77e-05 | 1294 | 220 | 22 | 30804502 |
| Pubmed | 2.83e-05 | 28 | 220 | 4 | 24427155 | ||
| Pubmed | TRIP4 NSRP1 HMG20A KNOP1 CEP170 JAK1 LARP4B DIMT1 ASPM TAF9 FAT3 PHRF1 TTC27 PRPF40A SLC5A11 ZZZ3 SMARCA2 SMARCD1 TTC39A RPAP2 | 3.15e-05 | 1116 | 220 | 20 | 31753913 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GAPVD1 PSMC2 CNTLN CEP350 ODF2L CEP120 WASHC5 RIOK1 WASHC2C IFT81 DYNC2I1 STIL LATS1 CCNB2 RASEF TMEM131 CBX8 | 3.44e-05 | 853 | 220 | 17 | 28718761 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | GAPVD1 BRIP1 ATR YTHDC1 THOC1 WASHC2C S100A16 PHRF1 ARHGAP35 PRPF40A OSBP LATS1 SMARCA2 SENP6 LIMCH1 EIF3B | 3.82e-05 | 774 | 220 | 16 | 15302935 |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 21285358 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 28925392 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 10512869 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 32681594 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 35815634 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 28570559 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 25075402 | ||
| Pubmed | E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice. | 3.98e-05 | 2 | 220 | 2 | 32259305 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 36274106 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 18202719 | ||
| Pubmed | Association of BARD1 and BRIP1 Gene Polymorphisms with the Risk of Uveal Melanoma. | 3.98e-05 | 2 | 220 | 2 | 37561379 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 26403473 | ||
| Pubmed | E2F-8: an E2F family member with a similar organization of DNA-binding domains to E2F-7. | 3.98e-05 | 2 | 220 | 2 | 15897886 | |
| Pubmed | Association between ABCC2 gene haplotypes and tenofovir-induced proximal tubulopathy. | 3.98e-05 | 2 | 220 | 2 | 17083032 | |
| Pubmed | Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer. | 3.98e-05 | 2 | 220 | 2 | 27452520 | |
| Pubmed | E2F7 represses a network of oscillating cell cycle genes to control S-phase progression. | 3.98e-05 | 2 | 220 | 2 | 22180533 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 12564955 | ||
| Pubmed | The Legionella pneumophila effector DrrA is sufficient to stimulate SNARE-dependent membrane fusion. | 3.98e-05 | 2 | 220 | 2 | 22264512 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 9034330 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 25801567 | ||
| Pubmed | Irinotecan-induced diarrhea: functional significance of the polymorphic ABCC2 transporter protein. | 3.98e-05 | 2 | 220 | 2 | 17185998 | |
| Pubmed | FNDC3A is required for adhesion between spermatids and Sertoli cells. | 3.98e-05 | 2 | 220 | 2 | 16904100 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 32098870 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 18498916 | ||
| Pubmed | CD4+ T Cell-Derived NGAL Modifies the Outcome of Ischemic Acute Kidney Injury. | 3.98e-05 | 2 | 220 | 2 | 31889023 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 20451671 | ||
| Pubmed | Structural characterization of a new binding motif and a novel binding mode in group 2 WW domains. | 3.98e-05 | 2 | 220 | 2 | 17915251 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 23430985 | ||
| Pubmed | Investigation of primary microcephaly in Bushehr province of Iran: novel STIL and ASPM mutations. | 3.98e-05 | 2 | 220 | 2 | 22989186 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 23222202 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 11352932 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 24465899 | ||
| Pubmed | IQSEC2 PSMC2 RYR2 CEP170 LARP4B STX1A WASHC5 CACNA1A DMXL2 NAA15 WASHC2C DNAJC16 DOCK9 ARHGAP35 OSBP NAMPT YKT6 TENM1 UBR3 EIF3B | 4.18e-05 | 1139 | 220 | 20 | 36417873 | |
| Pubmed | 4.24e-05 | 146 | 220 | 7 | 21399614 | ||
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 5.04e-05 | 150 | 220 | 7 | 22678362 | |
| Pubmed | The CEP19-RABL2 GTPase Complex Binds IFT-B to Initiate Intraflagellar Transport at the Ciliary Base. | 5.27e-05 | 12 | 220 | 3 | 28625565 | |
| Pubmed | PSMC2 E2F7 PGD CEP170 JAK1 LARP4B EIF3L GOLGA3 CNP RIOK1 FAM98A DIS3 EIF3B | 5.54e-05 | 551 | 220 | 13 | 34728620 | |
| Pubmed | GAPVD1 BRIP1 BARD1 CEP170 MBD4 CNP THOC1 SEC31A CCNB2 SMARCA2 SMARCD1 ZMYM1 CBX8 RPAP2 | 5.85e-05 | 634 | 220 | 14 | 34591612 | |
| Pubmed | TRIP4 KNOP1 CEP350 CEP170 LARP4B TCERG1 COL14A1 TAF9 NXF1 CNP THOC1 NRDE2 RIOK1 FAM98A PRPF40A NAMPT BAZ1A TMOD1 SMARCD1 LIMCH1 CBX8 LRRFIP2 | 6.51e-05 | 1371 | 220 | 22 | 36244648 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | YTHDC1 NSRP1 HMG20A KNOP1 ZSCAN29 CEP170 TCERG1 TAF9 NXF1 THOC1 NRDE2 DMXL2 SEC31A ARHGAP35 PRPF40A MRPL4 SMARCD1 EIF3B CBX8 | 6.53e-05 | 1082 | 220 | 19 | 38697112 |
| Pubmed | 6.81e-05 | 13 | 220 | 3 | 19064565 | ||
| Pubmed | CDK17 PGD NCAPG2 TRIP4 NSRP1 ASPM COL14A1 FAM135A GOLGA3 DMXL2 NAA15 DNAJC16 IFT81 FNDC3A SEC22B FAM98A PRPF40A MRPL4 YKT6 ANKRD11 AKAP13 TMEM131 ELP2 | 7.68e-05 | 1487 | 220 | 23 | 33957083 | |
| Pubmed | 8.63e-05 | 14 | 220 | 3 | 12432077 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | ABCC4 PSMC2 CEP170 JAK1 TMEM245 CNP FNDC3B S100A16 DNAJC16 SEC22B ARHGAP35 TMEM120A | 8.96e-05 | 499 | 220 | 12 | 22810586 |
| Pubmed | 1.00e-04 | 225 | 220 | 8 | 12168954 | ||
| Pubmed | PSMC2 PGD GNAI2 GOLGA3 NXF1 FNDC3A SEC22B FAM98A SEC31A NCAPH TTLL6 MEDAG TMOD1 LIMCH1 LRRFIP2 | 1.02e-04 | 754 | 220 | 15 | 35906200 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GAPVD1 PSMC2 NSRP1 KNOP1 CEP170 TCERG1 RIOK1 NAA15 WASHC2C ARHGAP35 NCAPH PRPF40A DIS3 NAMPT YKT6 BAZ1A SENP6 | 1.04e-04 | 934 | 220 | 17 | 33916271 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PSMC2 YTHDC1 KNOP1 DIMT1 TCERG1 WASHC5 EIF3L GNAI2 TAF9 NXF1 RIOK1 POLD2 TTC27 FAM98A NCAPH PRPF40A DIS3 MRPL4 NAMPT SMARCA2 EIF3B | 1.06e-04 | 1318 | 220 | 21 | 30463901 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CDK17 GAPVD1 IQSEC2 NCAPG2 TULP1 HMG20A CDR2L CEP170 CEP120 EIF3L CDADC1 COL14A1 CNP RIOK1 FAM210A IFT81 DYNC2I1 LCN2 DIS3 TMEM120A FGD6 | 1.09e-04 | 1321 | 220 | 21 | 27173435 |
| Pubmed | RGS2 and RGS4 proteins: New modulators of the κ-opioid receptor signaling. | 1.19e-04 | 3 | 220 | 2 | 25289860 | |
| Pubmed | Evolution of testis-specific kinases TSSK1B and TSSK2 in primates. | 1.19e-04 | 3 | 220 | 2 | 23258646 | |
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 30988386 | ||
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 11301010 | ||
| Pubmed | Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin. | 1.19e-04 | 3 | 220 | 2 | 29730765 | |
| Pubmed | The N-terminal end of nebulin interacts with tropomodulin at the pointed ends of the thin filaments. | 1.19e-04 | 3 | 220 | 2 | 11016930 | |
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 17273943 | ||
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 9405622 | ||
| Pubmed | YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs. | 1.19e-04 | 3 | 220 | 2 | 28984244 | |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 1.19e-04 | 3 | 220 | 2 | 15744052 | |
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 20019453 | ||
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 16877760 | ||
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 20961744 | ||
| Pubmed | Are there any new reliable markers to detect renal injury in obese children? | 1.19e-04 | 3 | 220 | 2 | 30035656 | |
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 25952649 | ||
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 29330301 | ||
| Pubmed | Atypical E2f functions are critical for pancreas polyploidization. | 1.19e-04 | 3 | 220 | 2 | 29329320 | |
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 19480556 | ||
| Pubmed | TP53, MSH4, and LATS1 germline mutations in a family with clustering of nervous system tumors. | 1.19e-04 | 3 | 220 | 2 | 25041856 | |
| Pubmed | 1.19e-04 | 3 | 220 | 2 | 17578901 | ||
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.95e-04 | 206 | 139 | 8 | 682 | |
| GeneFamily | Ankyrin repeat domain containing|BRCA1 B complex | 3.49e-04 | 4 | 139 | 2 | 1335 | |
| GeneFamily | Regulators of G-protein signaling | 5.34e-04 | 21 | 139 | 3 | 720 | |
| GeneFamily | DNA polymerases | 7.04e-04 | 23 | 139 | 3 | 535 | |
| GeneFamily | WASH complex | 8.63e-04 | 6 | 139 | 2 | 1331 | |
| GeneFamily | E2F transcription factors | 1.59e-03 | 8 | 139 | 2 | 982 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN | BRIP1 CNTLN ERI3 ASPM CDADC1 COL14A1 DYRK3 DOCK1 NCAPH E2F8 CCNB2 SMARCD1 | 1.19e-07 | 199 | 218 | 12 | M8031 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | BRIP1 GALNT3 ZGRF1 BARD1 E2F7 NCAPG2 ODF2L ASPM DDIT4 POLD2 STIL NCAPH E2F8 CCNB2 POLQ | 1.56e-06 | 402 | 218 | 15 | MM454 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CDK17 GAPVD1 ATR BARD1 CEP350 CEP170 LARP4B RASA1 FNDC3A STIL ZZZ3 BAZ1A SMARCA2 TMEM131 LIMCH1 R3HDM1 | 2.05e-06 | 466 | 218 | 16 | M13522 |
| Coexpression | ZHONG_PFC_C1_OPC | KIAA0586 BARD1 AK9 CNTLN SFR1 NCAPG2 ASPM S100A16 NCAPH CCNB2 POLQ | 5.42e-06 | 238 | 218 | 11 | M39096 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | PRTG ZGRF1 NCAPG2 FAT2 ASPM FNDC3B LRRN1 FAT3 NCAPH CCNB2 MTTP LIMCH1 | 8.83e-06 | 300 | 218 | 12 | M39059 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ABCC4 GALNT3 SPCS2 PTPN22 HMG20A CEP350 LARP4B DIMT1 VAMP1 MBD4 DMXL2 WASHC2C RASA1 FNDC3A SEC22B SEC31A RGS2 CUL5 YKT6 BAZ1A EDEM2 SENP6 TMEM131 EIF3B R3HDM1 LRRFIP2 | 1.03e-05 | 1215 | 218 | 26 | M41122 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK17 GAPVD1 ATR BARD1 CEP350 CEP170 LARP4B DOCK1 DMXL2 RASA1 DOCK9 FNDC3A STIL ARHGAP35 NAMPT ZZZ3 BAZ1A SMARCA2 AKAP13 TMEM131 R3HDM1 | 1.06e-05 | 856 | 218 | 21 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ATR SPP1 NSRP1 CEP350 CEP170 WASHC5 ASPM TAF9 MBD4 GAREM1 NAA15 DYNC2I1 ZZZ3 BAZ1A SMARCA2 ZMYM1 POLQ PUS7L | 1.06e-05 | 656 | 218 | 18 | M18979 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | ATR DOCK11 IQSEC2 YTHDC1 TRIP4 THOC1 NAA15 RASA1 FNDC3A PRPF40A NAMPT ANKRD11 UBR3 R3HDM1 RPAP2 | 3.55e-05 | 523 | 218 | 15 | M12707 |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 3.96e-05 | 195 | 218 | 9 | M13736 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | BRIP1 ZGRF1 KIAA0586 BARD1 E2F7 CNTLN PGD NCAPG2 CEP120 ASPM MBD4 THOC1 POLD2 STIL NCAPH E2F8 CD4 CCNB2 R3HDM1 POLQ TUBD1 | 4.11e-05 | 939 | 218 | 21 | M45768 |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP | 4.12e-05 | 196 | 218 | 9 | M8135 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | ATR DOCK11 IQSEC2 YTHDC1 TRIP4 THOC1 NAA15 RASA1 FNDC3A PRPF40A NAMPT ANKRD11 UBR3 R3HDM1 RPAP2 | 4.50e-05 | 534 | 218 | 15 | MM1054 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | GAPVD1 CEP350 CEP170 FAT2 DDIT4 DOCK9 FNDC3A ZZZ3 BAZ1A CCNB2 DOP1A | 4.64e-05 | 300 | 218 | 11 | M8702 |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 4.82e-05 | 200 | 218 | 9 | M8050 | |
| Coexpression | GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP | 4.82e-05 | 200 | 218 | 9 | M385 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 4.82e-05 | 200 | 218 | 9 | M3580 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CDK17 GAPVD1 ATR DOCK11 PTPN22 UBASH3A YTHDC1 CEP350 JAK1 VAMP1 TMC8 PLCB2 GNAI2 DDIT4 RASA1 DOCK9 ARHGAP35 ZBTB1 PRPF40A RGS2 ZNF800 CD4 LATS1 BAZ1A SMARCA2 ANKRD11 SENP6 AKAP13 | 4.93e-05 | 1492 | 218 | 28 | M40023 |
| Coexpression | FISCHER_DREAM_TARGETS | BRIP1 ZGRF1 BARD1 E2F7 SFR1 NCAPG2 KNOP1 TCERG1 ASPM THOC1 NAA15 POLD2 STIL NCAPH E2F8 CCNB2 EIF3B ZMYM1 R3HDM1 POLQ TUBD1 | 6.44e-05 | 969 | 218 | 21 | M149 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 6.94e-05 | 163 | 218 | 8 | M8235 | |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 7.24e-05 | 164 | 218 | 8 | M19957 | |
| Coexpression | VECCHI_GASTRIC_CANCER_EARLY_UP | BRIP1 SPP1 BARD1 E2F7 SFR1 NCAPG2 CDR2L ASPM LCN2 E2F8 CCNB2 EIF3B CDH3 | 8.05e-05 | 436 | 218 | 13 | M18855 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | BRIP1 BARD1 E2F7 NCAPG2 ASPM POLD2 STIL NCAPH E2F8 CCNB2 POLQ | 8.98e-05 | 323 | 218 | 11 | M2156 |
| Coexpression | BENPORATH_CYCLING_GENES | KIAA0586 BARD1 ABCC2 MBD4 DMXL2 STIL KIAA1586 NCAPH DIS3 E2F8 CCNB2 SMARCD1 AKAP13 ZMYM1 POLQ TUBD1 | 1.14e-04 | 648 | 218 | 16 | M8156 |
| Coexpression | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN | 1.27e-04 | 227 | 218 | 9 | M11234 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.38e-04 | 180 | 218 | 8 | M8239 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 1.38e-04 | 180 | 218 | 8 | M2961 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ZGRF1 KIAA0586 YTHDC1 NSRP1 CEP170 ODF2L CEP120 WASHC5 TMEM245 TAF9 FAM135A RIOK1 WASHC2C FNDC3A NCAPH ZBTB1 ZZZ3 SLC16A4 PTCD2 TMEM131 ELP2 FGD6 | 4.42e-08 | 564 | 209 | 22 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ZGRF1 KIAA0586 CNTLN NSRP1 CEP170 ODF2L TMEM245 TAF9 FAM135A LRRN1 SLITRK4 DYNC2I1 FNDC3A ARHGAP35 ZBTB1 PRPF40A ZZZ3 SLC16A4 BAZ1A PTCD2 UBR3 TMEM131 ZMYM1 | 6.93e-08 | 629 | 209 | 23 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | TMEM69 CEP350 STX1A ASPM MED12L DOCK1 NAA15 RASA1 PRPF40A CUL5 BAZ1A ERCC6L2 ANKRD11 LIMCH1 R3HDM1 | 1.46e-06 | 339 | 209 | 15 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ATR SPP1 ZGRF1 KIAA0586 E2F7 CNTLN TRIP4 NSRP1 ZSCAN29 CEP350 ODF2L CEP120 DIMT1 TCERG1 ASPM TAF9 DYRK3 THOC1 LRRN1 RASA1 IFT81 DYNC2I1 STIL NCAPH PRPF40A E2F8 CUL5 ZNF800 BAZ1A R3HDM1 CBX8 | 2.17e-06 | 1257 | 209 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | TMEM69 E2F7 NSRP1 DIMT1 TCERG1 TMEM245 ASPM TAF9 THOC1 DOCK1 CPNE9 FAM98A PRPF40A SLC16A4 BAZ1A ANKRD11 TMEM131 | 4.33e-06 | 469 | 209 | 17 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ATR SPIB TMEM69 CNTLN KCNIP3 ZSCAN29 CEP120 DIMT1 ASPM FAM135A THOC1 CACNA1A RASA1 SLITRK4 DYNC2I1 STIL NCAPH ZBTB1 PRPF40A CUL5 ZNF800 BAZ1A CCNB2 PTCD2 UBR3 TMEM131 ZMYM1 R3HDM1 FGD6 CBX8 | 5.72e-06 | 1252 | 209 | 30 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | PIGN ABCC4 BARD1 RYR2 CEP350 CEP170 KCNK2 ASPM COL14A1 FAM135A AKAP6 DOCK1 GPR22 LRRN1 FAM210A FAT3 ADAMTS5 RGS4 LATS1 ERCC6L2 TENM1 LGI1 GABRA3 | 6.32e-06 | 818 | 209 | 23 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | TMEM69 CNTLN NSRP1 FAM135A THOC1 CTC1 DYNC2I1 NCAPH ZBTB1 PRPF40A BAZ1A PTCD2 UBR3 TMEM131 ZMYM1 FGD6 | 6.38e-06 | 432 | 209 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | PRTG DOCK11 TMEM69 BARD1 CNTLN NSRP1 TAF9 FAM135A THOC1 CPNE9 CTC1 DYNC2I1 NCAPH ZBTB1 PRPF40A MRPL4 BAZ1A PTCD2 TMOD1 UBR3 RASEF TMEM131 LIMCH1 ZMYM1 FGD6 | 1.53e-05 | 989 | 209 | 25 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TMEM69 KIAA0586 E2F7 CNTLN KCNIP3 TULP1 ZSCAN29 ODF2L DIMT1 ASPM CACNA1A LRRN1 RASA1 FAT3 SLITRK4 DYNC2I1 STIL NCAPH PRPF40A E2F8 CUL5 ZNF800 BAZ1A ZMYM1 R3HDM1 GABRA3 | 1.71e-05 | 1060 | 209 | 26 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CDK17 DOCK11 TMEM69 E2F7 TRIP4 LARP4B TCERG1 ASPM RASA1 FAM98A STIL ZBTB1 PRPF40A ZNF800 BAZ1A ANKRD11 POLQ | 2.22e-05 | 532 | 209 | 17 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 2.62e-05 | 88 | 209 | 7 | GSM399452_100 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 3.03e-05 | 90 | 209 | 7 | GSM399397_100 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ATR SPP1 ZGRF1 KIAA0586 E2F7 CNTLN TRIP4 NSRP1 ZSCAN29 CEP350 ODF2L CEP120 DIMT1 TCERG1 ASPM TAF9 DYRK3 THOC1 LRRN1 RASA1 IFT81 DYNC2I1 STIL NCAPH PRPF40A E2F8 CUL5 ZNF800 BAZ1A R3HDM1 CBX8 | 4.13e-05 | 1459 | 209 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | BRIP1 SPIB ZGRF1 BARD1 E2F7 NCAPG2 ASPM MBD4 STIL LCN2 NCAPH E2F8 CCNB2 POLQ | 5.76e-05 | 409 | 209 | 14 | GSM399452_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | BRIP1 GALNT3 ZGRF1 BARD1 E2F7 PTPN22 UBASH3A NCAPG2 ASPM STIL NCAPH E2F8 CCNB2 POLQ | 5.92e-05 | 410 | 209 | 14 | GSM538387_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | KIAA0586 NSRP1 ODF2L TCERG1 ASPM SLITRK4 LATS1 SLC16A4 BAZ1A POLQ FGD6 LRRFIP2 | 6.36e-05 | 311 | 209 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | KIAA0586 COG3 NSRP1 ODF2L TCERG1 ASPM CDADC1 GOLGA3 PURG CACNA1A DMXL2 LRRN1 FAT3 SLITRK4 ZNF800 LATS1 SLC16A4 BAZ1A ERCC6L2 POLQ LRRFIP2 | 7.67e-05 | 831 | 209 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | PIGN BARD1 RYR2 CEP350 ASPM COL14A1 DOCK1 FAM210A FAT3 LATS1 ERCC6L2 GABRA3 | 1.12e-04 | 330 | 209 | 12 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | B cells, preB.FrD.BM, CD19+ IgM- CD45R+ CD43-, Bone marrow, avg-3 | BRIP1 SPIB NCAPG2 ASPM MBD4 CNP STIL LCN2 NCAPH RGS2 E2F8 CCNB2 FGD6 | 1.15e-04 | 383 | 209 | 13 | GSM399448_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | PIGN TUBA3E RYR2 CEP350 JAK1 STX1A COL14A1 DOCK1 RASA1 FAT3 SLITRK4 ERCC6L2 GABRA3 | 1.22e-04 | 385 | 209 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | GAPVD1 JAK1 ASPM COL14A1 GNAI2 GAREM1 NAA15 FAT3 FRMPD2 SLITRK4 ANO1 ADAMTS5 LCN2 RGS2 C4orf54 ZNF800 SMARCA2 ANKRD11 MEDAG R3HDM1 | 1.26e-04 | 797 | 209 | 20 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.76e-04 | 201 | 209 | 9 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | PIGN ABCC4 TUBA3E RYR2 CEP350 JAK1 STX1A KCNK2 COL14A1 GNAI2 DOCK1 GPR22 LRRN1 RASA1 FAT3 SLITRK4 RGS4 ERCC6L2 LGI1 GABRA3 | 1.77e-04 | 818 | 209 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | BRIP1 GALNT3 SPP1 BARD1 PTPN22 UBASH3A NCAPG2 ASPM STIL NCAPH E2F8 CCNB2 | 2.43e-04 | 359 | 209 | 12 | GSM605773_500 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 2.65e-04 | 90 | 209 | 6 | GSM399403_100 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.67e-04 | 168 | 209 | 8 | gudmap_developingGonad_P2_ovary_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NEB ZSCAN29 CEP350 ASPM MED12L CACNA1A PIGB LRRN1 FAT3 SLITRK4 DYNC2I1 ZNF800 LATS1 BAZ1A AKAP13 POLQ DOP1A | 2.72e-04 | 654 | 209 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZGRF1 KIAA0586 NSRP1 CEP170 ODF2L TMEM245 TAF9 NXF1 LRRN1 FNDC3A ARHGAP35 ZBTB1 CUL5 SLC16A4 PTCD2 SENP6 | 2.84e-04 | 595 | 209 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | PRTG CNTLN ZSCAN29 CEP350 ASPM MED12L C1QB CACNA1A PIGB LRRN1 FAT3 ANO1 DYNC2I1 PRPF40A ZNF800 LATS1 BAZ1A ANKRD11 TMOD1 UBR3 POLQ DOP1A | 2.90e-04 | 983 | 209 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | ZGRF1 CNTLN NCAPG2 ASPM MED12L DOCK1 STIL LCN2 NCAPH E2F8 CCNB2 TMOD1 POLQ | 3.04e-04 | 423 | 209 | 13 | GSM791126_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | ABCC4 GALNT3 TMEM69 CEP350 STX1A ASPM MED12L DOCK1 NAA15 RASA1 LCN2 PRPF40A CUL5 BAZ1A ERCC6L2 TENM1 ANKRD11 LIMCH1 R3HDM1 | 3.76e-04 | 801 | 209 | 19 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | BRIP1 SPIB BARD1 NCAPG2 ASPM MBD4 STIL NCAPH E2F8 CCNB2 TMEM131 FGD6 | 4.06e-04 | 380 | 209 | 12 | GSM538207_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | PIGN RYR2 CEP350 CEP170 JAK1 KCNK2 ASPM COL14A1 DOCK1 DDIT4 FAM210A CERT1 PRPF40A RGS4 E2F8 LATS1 ERCC6L2 MEDAG GABRA3 | 4.38e-04 | 811 | 209 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | PRTG ABCC4 BRIP1 BARD1 NCAPG2 ASPM GAREM1 LRRN1 S100A16 FAT3 ANO1 FAM98A NCAPH E2F8 BAZ1A TMOD1 RASEF FGD6 | 4.61e-04 | 749 | 209 | 18 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | BRIP1 SPIB ZGRF1 BARD1 NCAPG2 ASPM STIL LCN2 NCAPH E2F8 CCNB2 POLQ | 4.89e-04 | 388 | 209 | 12 | GSM538352_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PRTG BRIP1 ATR ZGRF1 BARD1 TUBA3E NCAPG2 ZSCAN29 MED12L FAM135A NR1D2 DMXL2 IFT81 TTC27 BAZ1A CCNB2 ERCC6L2 FGD6 DOP1A | 5.01e-04 | 820 | 209 | 19 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | BRIP1 ATR ZGRF1 KIAA0586 BARD1 TUBA3E NCAPG2 MED12L FAM135A NR1D2 DMXL2 NAA15 TTC27 DIS3 E2F8 CCNB2 EIF3B ZMYM1 FGD6 | 5.16e-04 | 822 | 209 | 19 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | BRIP1 SPIB ZGRF1 BARD1 NCAPG2 ASPM DOCK9 STIL NCAPH E2F8 CCNB2 FGD6 | 5.73e-04 | 395 | 209 | 12 | GSM538340_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | PIGN RYR2 CEP350 JAK1 ASPM COL14A1 DOCK1 FAM210A CERT1 LATS1 ERCC6L2 GABRA3 | 5.99e-04 | 397 | 209 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | BRIP1 ZGRF1 BARD1 NCAPG2 ASPM STIL NCAPH E2F8 CD4 CCNB2 MEDAG POLQ | 6.12e-04 | 398 | 209 | 12 | GSM399397_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TMEM69 KIAA0586 E2F7 CNTLN KCNIP3 TULP1 ZSCAN29 ODF2L DIMT1 ASPM PLCB2 CACNA1A LRRN1 RASA1 FAT3 SLITRK4 DYNC2I1 STIL NCAPH PRPF40A E2F8 CUL5 ZNF800 BAZ1A ZMYM1 R3HDM1 GABRA3 | 7.27e-04 | 1414 | 209 | 27 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | BRIP1 ZGRF1 BARD1 E2F7 PTPN22 UBASH3A NCAPG2 TMC8 ASPM STIL NCAPH E2F8 POLQ | 1.84e-11 | 195 | 220 | 13 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | BRIP1 ZGRF1 BARD1 E2F7 NCAPG2 ASPM MED12L STIL NCAPH E2F8 CCNB2 POLQ | 1.12e-10 | 180 | 220 | 12 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | BRIP1 ZGRF1 BARD1 E2F7 NCAPG2 CASZ1 ASPM FAT3 STIL NCAPH E2F8 POLQ | 2.09e-10 | 190 | 220 | 12 | e83fa8b711aa79a1767818474f1c193b674b1c31 |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | BRIP1 ZGRF1 BARD1 E2F7 PTPN22 UBASH3A NCAPG2 ASPM STIL NCAPH E2F8 POLQ | 2.22e-10 | 191 | 220 | 12 | bae388e0e9447d576e68465d73d8313ef6925ffa |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | BRIP1 E2F7 SFR1 NCAPG2 TMEM245 ASPM PURG STIL E2F8 SLC5A11 MEDAG POLQ | 3.17e-10 | 197 | 220 | 12 | 038fd92750257d43d5e980fd06d77742b543f11a |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | BRIP1 ZGRF1 BARD1 E2F7 NCAPG2 ASPM STIL NCAPH E2F8 CCNB2 POLQ | 2.27e-09 | 185 | 220 | 11 | 30e041d6f6e310d64809e9d6d93cd30052972f3b |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | BRIP1 ZGRF1 BARD1 E2F7 NCAPG2 ASPM DOCK9 STIL NCAPH E2F8 POLQ | 3.01e-09 | 190 | 220 | 11 | 31de1727822e9818652946dfb962daee77ffad68 |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | BRIP1 ZGRF1 BARD1 E2F7 NCAPG2 ASPM STIL NCAPH E2F8 CCNB2 POLQ | 3.95e-09 | 195 | 220 | 11 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | BRIP1 ZGRF1 BARD1 E2F7 NCAPG2 ASPM STIL NCAPH E2F8 CCNB2 POLQ | 4.63e-09 | 198 | 220 | 11 | b2868a897dd96494cf1829c30e0ce508f52efdf3 |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | BRIP1 ZGRF1 BARD1 E2F7 NCAPG2 ASPM STIL NCAPH E2F8 CCNB2 POLQ | 4.63e-09 | 198 | 220 | 11 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | BRIP1 ZGRF1 BARD1 E2F7 NCAPG2 ASPM STIL NCAPH E2F8 CCNB2 POLQ | 4.63e-09 | 198 | 220 | 11 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | CEP350 CEP170 ODF2L NAA15 DYNC2I1 SEC31A PRPF40A ZNF800 BAZ1A SMARCA2 ANKRD11 | 4.63e-09 | 198 | 220 | 11 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | BRIP1 ZGRF1 BARD1 E2F7 NCAPG2 ASPM STIL NCAPH E2F8 CCNB2 POLQ | 4.88e-09 | 199 | 220 | 11 | be2276c9a1994579ba1d2998b49bf549c1324d44 |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | BRIP1 ZGRF1 BARD1 E2F7 NCAPG2 ASPM STIL NCAPH E2F8 CCNB2 POLQ | 5.14e-09 | 200 | 220 | 11 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.14e-09 | 163 | 220 | 10 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-08 | 168 | 220 | 10 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-08 | 169 | 220 | 10 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-08 | 169 | 220 | 10 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-08 | 175 | 220 | 10 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.36e-08 | 180 | 220 | 10 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-08 | 187 | 220 | 10 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | CV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 4.34e-08 | 192 | 220 | 10 | a249787f7e2f50af49bd7d4752c411a067a5e3d3 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 4.56e-08 | 193 | 220 | 10 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-08 | 193 | 220 | 10 | e45ce9cf8421512b57f157c24b64793b47b4ba4b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.78e-08 | 194 | 220 | 10 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 4.78e-08 | 194 | 220 | 10 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.02e-08 | 195 | 220 | 10 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-08 | 195 | 220 | 10 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.02e-08 | 195 | 220 | 10 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.02e-08 | 195 | 220 | 10 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.27e-08 | 196 | 220 | 10 | bf1d3fae8c01bb3d17c2dafad92b94937c663acd | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.27e-08 | 196 | 220 | 10 | 0c003a767c3b58605099dab64b9df0d8e5d8bc4b | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.27e-08 | 196 | 220 | 10 | 6d80e23f6a1725a3f5ea7263233c55c2ea56f977 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.27e-08 | 196 | 220 | 10 | 3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.27e-08 | 196 | 220 | 10 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.27e-08 | 196 | 220 | 10 | 4f649e3bfd21f21682678828673843a7d51c4ff2 | |
| ToppCell | BAL-Control-Myeloid-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.27e-08 | 196 | 220 | 10 | 799c290fb3dfacb666dd0dc3c43ec8a86b697ec7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.53e-08 | 197 | 220 | 10 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | Control-Myeloid-proliferating_Myeloid_cells|Control / Disease group,lineage and cell class (2021.01.30) | 5.53e-08 | 197 | 220 | 10 | ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.53e-08 | 197 | 220 | 10 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.80e-08 | 198 | 220 | 10 | ed86b0247006befe55400c287d334d2202b470bd | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.80e-08 | 198 | 220 | 10 | bcfe7b6d91f2e2f145cb2660b65fd2a6c1134b86 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.80e-08 | 198 | 220 | 10 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.80e-08 | 198 | 220 | 10 | 085ba270f9defbf5ef45108c6d870e1d7c428479 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.80e-08 | 198 | 220 | 10 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.80e-08 | 198 | 220 | 10 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.08e-08 | 199 | 220 | 10 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-08 | 199 | 220 | 10 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.08e-08 | 199 | 220 | 10 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 6.08e-08 | 199 | 220 | 10 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-08 | 199 | 220 | 10 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 6.08e-08 | 199 | 220 | 10 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.08e-08 | 199 | 220 | 10 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 6.08e-08 | 199 | 220 | 10 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 6.08e-08 | 199 | 220 | 10 | 6321140a1ebc1ff793fb6221a31e884368e42fa5 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.37e-08 | 200 | 220 | 10 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Biopsy_Other_PF-Immune-Proliferating_Macrophages|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.37e-08 | 200 | 220 | 10 | 61473e8613f39a92002d5b631e6bd563735566e4 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-08 | 200 | 220 | 10 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | BL-critical-LOC-Lymphoid-Treg|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.37e-08 | 200 | 220 | 10 | 04d95a9102248e98eed069840ea6d3d23a243fd5 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-T/NK_proliferative|ICU-SEP / Disease, condition lineage and cell class | 6.37e-08 | 200 | 220 | 10 | ae500c8b7c2162cadd31bf44ee9dc3271192cf17 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-08 | 200 | 220 | 10 | 28c702449040ac15fe4e0c6340bb6f137e88539d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-07 | 163 | 220 | 9 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-07 | 165 | 220 | 9 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-07 | 167 | 220 | 9 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-07 | 167 | 220 | 9 | bad33497ceeab968a7eb8a48b921c6f936390743 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-07 | 167 | 220 | 9 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-07 | 169 | 220 | 9 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-07 | 169 | 220 | 9 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-07 | 169 | 220 | 9 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-07 | 171 | 220 | 9 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-07 | 171 | 220 | 9 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-07 | 171 | 220 | 9 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK|bone_marrow / Manually curated celltypes from each tissue | 2.10e-07 | 173 | 220 | 9 | 8a9dd85f718564c07cf3120ad648daeb60c94fc5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-07 | 173 | 220 | 9 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-07 | 174 | 220 | 9 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-07 | 174 | 220 | 9 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-07 | 174 | 220 | 9 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-07 | 177 | 220 | 9 | ba701d3c90722d8bff70d0fa651899305cdad257 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.80e-07 | 179 | 220 | 9 | e1bfd553c043ebc070ccf8545d489ba16d9b2ef4 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-07 | 179 | 220 | 9 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-07 | 180 | 220 | 9 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.08e-07 | 181 | 220 | 9 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.08e-07 | 181 | 220 | 9 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 3.38e-07 | 183 | 220 | 9 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.54e-07 | 184 | 220 | 9 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.54e-07 | 184 | 220 | 9 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.54e-07 | 184 | 220 | 9 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.54e-07 | 184 | 220 | 9 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 3.54e-07 | 184 | 220 | 9 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-07 | 184 | 220 | 9 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 3.70e-07 | 185 | 220 | 9 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.87e-07 | 186 | 220 | 9 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-07 | 187 | 220 | 9 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-07 | 187 | 220 | 9 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-07 | 187 | 220 | 9 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-07 | 189 | 220 | 9 | bfa3ed1360991a3e32fad133017c413f8adc1eba | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-07 | 189 | 220 | 9 | 96f10c63656e446b4bb712f012e91ae986f8c2d0 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-07 | 189 | 220 | 9 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-07 | 190 | 220 | 9 | 185ae04c68f825cd346aa65072cc5da6a39dff4a | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.63e-07 | 190 | 220 | 9 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| Disease | Drug toxicity | 3.35e-05 | 84 | 213 | 6 | C0013221 | |
| Disease | Adverse reaction to drug | 3.35e-05 | 84 | 213 | 6 | C0041755 | |
| Disease | alcohol consumption measurement | MYT1L PIGN UBASH3A HMG20A STX1A DIMT1 ERI3 CDADC1 GNAI2 MBD4 NR1D2 AKAP6 DOCK1 CACNA1A CRTAC1 SIL1 ZZZ3 TTLL6 ANKRD11 MTTP PTCD2 SENP6 CBX8 | 3.62e-05 | 1242 | 213 | 23 | EFO_0007878 |
| Disease | Foot Deformities | 5.19e-05 | 2 | 213 | 2 | C0016506 | |
| Disease | Cardiac arrhythmia | 5.19e-05 | 2 | 213 | 2 | cv:C0003811 | |
| Disease | Genetic cardiac rhythm disease | 5.19e-05 | 2 | 213 | 2 | cv:C5681782 | |
| Disease | Short Rib-Polydactyly Syndrome | 1.01e-04 | 13 | 213 | 3 | C0036996 | |
| Disease | Metabolic Bone Disorder | 1.27e-04 | 14 | 213 | 3 | C0005944 | |
| Disease | Saldino-Noonan Syndrome | 1.27e-04 | 14 | 213 | 3 | C0036069 | |
| Disease | Majewski Syndrome | 1.27e-04 | 14 | 213 | 3 | C0024507 | |
| Disease | opioid abuse (biomarker_via_orthology) | 1.55e-04 | 3 | 213 | 2 | DOID:11206 (biomarker_via_orthology) | |
| Disease | Hand deformities | 1.55e-04 | 3 | 213 | 2 | C0018564 | |
| Disease | Osteopenia | 1.58e-04 | 15 | 213 | 3 | C0029453 | |
| Disease | Testicular Germ Cell Tumor | 1.89e-04 | 73 | 213 | 5 | EFO_1000566 | |
| Disease | Tumoral calcinosis | 2.38e-04 | 42 | 213 | 4 | C0263628 | |
| Disease | Calcinosis | 2.38e-04 | 42 | 213 | 4 | C0006663 | |
| Disease | Microcalcification | 2.38e-04 | 42 | 213 | 4 | C0521174 | |
| Disease | Hyperbilirubinemia | 3.08e-04 | 4 | 213 | 2 | C0020433 | |
| Disease | Malignant neoplasm of breast | BRIP1 SPP1 BARD1 COG3 KCNIP3 ALKBH8 C1QB GNAI2 PURG AKAP6 FNDC3B FAM210A RGS2 CUL5 TENM1 ANKRD30A SMARCD1 CLUL1 DOP1A | 3.14e-04 | 1074 | 213 | 19 | C0006142 |
| Disease | familial hyperlipidemia (biomarker_via_orthology) | 3.30e-04 | 19 | 213 | 3 | DOID:1168 (biomarker_via_orthology) | |
| Disease | bilirubin metabolic disorder (implicated_via_orthology) | 5.11e-04 | 5 | 213 | 2 | DOID:2741 (implicated_via_orthology) | |
| Disease | bladder disease (biomarker_via_orthology) | 5.11e-04 | 5 | 213 | 2 | DOID:365 (biomarker_via_orthology) | |
| Disease | Familial ventricular tachycardia | 5.11e-04 | 5 | 213 | 2 | C0340485 | |
| Disease | bilirubin metabolic disorder (is_implicated_in) | 7.63e-04 | 6 | 213 | 2 | DOID:2741 (is_implicated_in) | |
| Disease | response to perphenazine | 8.53e-04 | 26 | 213 | 3 | GO_0097334 | |
| Disease | creatine kinase measurement | 8.81e-04 | 59 | 213 | 4 | EFO_0004534 | |
| Disease | hypothyroidism | 1.12e-03 | 284 | 213 | 8 | EFO_0004705 | |
| Disease | Crohn's disease (is_implicated_in) | 1.30e-03 | 30 | 213 | 3 | DOID:8778 (is_implicated_in) | |
| Disease | lactase-phlorizin hydrolase measurement | 1.41e-03 | 8 | 213 | 2 | EFO_0801753 | |
| Disease | Rheumatoid Arthritis | 1.71e-03 | 174 | 213 | 6 | C0003873 | |
| Disease | Lupus Erythematosus, Systemic | 1.76e-03 | 71 | 213 | 4 | C0024141 | |
| Disease | Graves Disease | 1.81e-03 | 9 | 213 | 2 | C0018213 | |
| Disease | forced expiratory volume | AK9 CNTLN CASZ1 RYR2 CEP120 KCNK2 MBD4 GAREM1 DOCK9 STIL ERCC6L2 SMARCA2 FGD6 CBX8 | 1.88e-03 | 789 | 213 | 14 | EFO_0004314 |
| Disease | multiple sclerosis (is_implicated_in) | 1.95e-03 | 73 | 213 | 4 | DOID:2377 (is_implicated_in) | |
| Disease | Ovarian Cysts | 2.05e-03 | 35 | 213 | 3 | C0029927 | |
| Disease | Corpus Luteum Cyst | 2.05e-03 | 35 | 213 | 3 | C0010093 | |
| Disease | glomerulosclerosis (biomarker_via_orthology) | 2.25e-03 | 10 | 213 | 2 | DOID:0050851 (biomarker_via_orthology) | |
| Disease | Jeune thoracic dystrophy | 2.73e-03 | 11 | 213 | 2 | C0265275 | |
| Disease | Diabetic Cardiomyopathies | 2.73e-03 | 11 | 213 | 2 | C0853897 | |
| Disease | colon cancer (implicated_via_orthology) | 2.73e-03 | 11 | 213 | 2 | DOID:219 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 3.01e-03 | 40 | 213 | 3 | C0598589 | |
| Disease | sleep measurement | 3.04e-03 | 135 | 213 | 5 | EFO_0004870 | |
| Disease | intercellular adhesion molecule 5 measurement | 3.84e-03 | 13 | 213 | 2 | EFO_0008164 | |
| Disease | Genetic chronic primary adrenal insufficiency | 3.84e-03 | 13 | 213 | 2 | Orphanet_101960 | |
| Disease | concentration of large LDL particles measurement | 3.95e-03 | 44 | 213 | 3 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 3.95e-03 | 44 | 213 | 3 | EFO_0022225 | |
| Disease | myocardial infarction | 4.08e-03 | 350 | 213 | 8 | EFO_0000612 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 4.46e-03 | 14 | 213 | 2 | C0677776 | |
| Disease | Neurodevelopmental Disorders | 4.67e-03 | 93 | 213 | 4 | C1535926 | |
| Disease | longevity | 4.74e-03 | 284 | 213 | 7 | EFO_0004300 | |
| Disease | neuroimaging measurement, brain volume measurement | 4.92e-03 | 286 | 213 | 7 | EFO_0004346, EFO_0006930 | |
| Disease | Down syndrome (implicated_via_orthology) | 5.12e-03 | 15 | 213 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | Generalized hypotonia | 5.12e-03 | 15 | 213 | 2 | C1858120 | |
| Disease | BMI-adjusted leptin measurement | 5.12e-03 | 15 | 213 | 2 | EFO_0007793 | |
| Disease | Autosomal recessive primary microcephaly | 5.12e-03 | 15 | 213 | 2 | cv:C3711387 | |
| Disease | phospholipids in medium LDL measurement | 5.35e-03 | 49 | 213 | 3 | EFO_0022183 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 5.41e-03 | 220 | 213 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | Intellectual Disability | 5.42e-03 | 447 | 213 | 9 | C3714756 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 5.82e-03 | 16 | 213 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | Acute kidney injury | 6.25e-03 | 101 | 213 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 6.25e-03 | 101 | 213 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 6.25e-03 | 101 | 213 | 4 | C0022660 | |
| Disease | total lipids in LDL measurement | 6.32e-03 | 52 | 213 | 3 | EFO_0022308 | |
| Disease | acute kidney failure (is_marker_for) | 6.57e-03 | 17 | 213 | 2 | DOID:3021 (is_marker_for) | |
| Disease | free cholesterol in small LDL measurement | 6.66e-03 | 53 | 213 | 3 | EFO_0022271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSEDNVVRKYAKKIT | 81 | O00555 | |
| KSTQKRKSFTSLYKD | 951 | Q5SW79 | |
| YFQRKKKDIKLSTQF | 121 | P0CF97 | |
| QDKSISLYQRFKKTF | 116 | Q96ND0 | |
| KTLAYRGFIFKQTSK | 321 | O43414 | |
| YKALFKEIFSRIQKT | 436 | Q86X02 | |
| KYSKIFEQKDRLSQS | 726 | P55884 | |
| LLKKDYRKETKSNSF | 366 | Q6UB99 | |
| SKKVRYVVSKASVQT | 151 | Q99728 | |
| KAYKAVVNDATIFKL | 371 | Q93034 | |
| VRLSALVKSKQKAYF | 231 | Q2NKJ3 | |
| AYARKQSVKSRKVTT | 146 | Q0P641 | |
| LRKEKYSTDAKIKTF | 271 | Q9NXG0 | |
| FKTKNVTKALTTYVV | 2636 | Q8IZF6 | |
| QSNYKLSKTEKKFLR | 6 | Q96BT7 | |
| VARASKYDFFIQKLK | 306 | Q86V15 | |
| KDQTRFTAYLALKKK | 766 | Q9UNA0 | |
| YFISLNVTKERKKSK | 236 | Q8N139 | |
| SGTKVSRTFSYIKNK | 1741 | Q12802 | |
| KLKEESLTKRASQYS | 1151 | Q9BXX3 | |
| KKSFLEDIRKALYAS | 316 | P52209 | |
| KQKTSKEYLSAFLAA | 736 | Q5JWR5 | |
| ETFIRYIFTKKRKQS | 2626 | Q8TDJ6 | |
| TSYKCDFIQKITKTL | 206 | Q9BWV3 | |
| RLYRKANKSSKLVSA | 161 | P01008 | |
| PSKYSKFKRASQSER | 1051 | Q96MT7 | |
| AAVTIQSKYRAYKTK | 2046 | Q8IZT6 | |
| KKATIFVQRKYRATI | 2431 | Q8IZT6 | |
| TLASYRSKATKERDK | 296 | Q9NRL2 | |
| KSSVKYSVQLEDRKT | 51 | Q7Z5Q5 | |
| QKRYILKRDNSSFDK | 251 | Q15032 | |
| EAFVTSAYKKKLQER | 141 | Q9H0G5 | |
| SNLKFKEKSAEYTAL | 561 | Q9ULJ1 | |
| DSVVYGLRSKSKKFR | 161 | P10451 | |
| NTIRRKTKDAFYKNI | 461 | P20936 | |
| DNAKSFSSQKAYKIV | 531 | Q8IZ41 | |
| KFKVAKQLASALSYL | 691 | P23458 | |
| KSDYIIRTLKVKFNS | 166 | Q9Y2R2 | |
| LKRFTSYVQEKTAGK | 606 | Q9Y5P4 | |
| KQAFKAVFRKIFSAS | 296 | A6NIJ9 | |
| SKQFEYDIKTKNITR | 441 | Q9H306 | |
| TYSLKNAKAAAQKFI | 181 | Q9H511 | |
| KDTKYARILAFLQSK | 111 | A6NFD8 | |
| YYSAISEAKIKKRQA | 166 | Q86YW9 | |
| LARKVDTKALYATKT | 721 | O95835 | |
| KNTKSRNRKVTIYSF | 1051 | Q38SD2 | |
| SFSQYRCKTAKKSEE | 196 | Q9Y262 | |
| QKTEAYKVFSRKTQD | 171 | Q9NP66 | |
| QKKKILVTYSFRQSF | 1011 | Q5JU85 | |
| QDSAFSYRDAKKKLR | 1111 | Q14C86 | |
| IYDKFQRATSIKRKL | 351 | O95069 | |
| YRKKREEKFTSSQTQ | 501 | Q92615 | |
| SKEKILTDSYKFRAK | 426 | Q8WYA1 | |
| KREKYSKEKSNSFSD | 236 | Q8WVS4 | |
| YSLKRSRSKFQKNTV | 506 | Q9BV94 | |
| AKYLTKKTQAASVEA | 261 | P49005 | |
| VKYSSKSKFDAITKQ | 1166 | Q9P2D6 | |
| KLSSLKFEKAVYRVQ | 356 | Q9NYQ8 | |
| YKAKKIVSTIAINSA | 691 | Q9HCI6 | |
| SLAEYFKDSRNVKKL | 431 | Q9UBU9 | |
| LVYSLRNKEVKSAFK | 286 | Q8NH48 | |
| KQAAAIIKAVDSKYT | 271 | P55157 | |
| EILYAKTFKEKSRLN | 161 | Q9H706 | |
| SRKQVERYFTKKSVG | 216 | Q9H7Z3 | |
| VFSYVKIIAKVKSSS | 216 | Q6U736 | |
| VSRTASQADIKKAYK | 36 | Q9Y2G8 | |
| LFSIKKTKQLRSEVY | 816 | Q9P1Y6 | |
| NKIFYIDRNASKSVK | 441 | Q1ED39 | |
| LSAVATQKKKADRYI | 181 | Q8N7Z2 | |
| ALSAVTTQKKKADRY | 131 | H0YM25 | |
| TKTYNSVSKVDKISR | 446 | P34903 | |
| TKRSSTTKLYLAKQV | 56 | Q92887 | |
| RKNKEKIITYASSSD | 46 | Q9Y4A0 | |
| YEILKRTTCTKAKYS | 251 | Q5XXA6 | |
| TKFLQYESKKRVSAE | 451 | Q00537 | |
| LVYSLRNKEVKSAFK | 286 | Q96R08 | |
| KIVYSTYSRKSAKEV | 671 | Q6NUT2 | |
| LVKKKTTSFYECATQ | 86 | Q8NGG0 | |
| KTSKSSKIRSLADYR | 236 | Q08378 | |
| QEIKITSKFRGKYLS | 541 | P22059 | |
| VQTKKDTSKERTYAF | 121 | Q5VYS4 | |
| FNTLRSLYKDKEKVA | 326 | Q9BXJ9 | |
| ANRQISEYKFKLSKA | 626 | Q9Y608 | |
| YRSKARKSSASKTAQ | 971 | Q2VWP7 | |
| ARSKYKEAKESFQRF | 456 | O75400 | |
| AKLSAKKQASIYRDE | 136 | Q9BX63 | |
| SYTVRSKKIFLSKLI | 231 | Q9UJ42 | |
| AAALTETAKQVYFKR | 1281 | O15439 | |
| DKSYNVTSVLFRKKK | 81 | P80188 | |
| LVKKKTTSFYECATQ | 86 | Q8NGP2 | |
| KKIQITSSVFKVSAY | 211 | Q9BRQ4 | |
| AKKRDITAFYDSLKL | 1811 | Q13535 | |
| FNLKDVRKRVKSTYS | 501 | Q711Q0 | |
| EFKRYVNKLRSKSTV | 396 | Q8WYA0 | |
| KKTSYRETALSARKN | 151 | Q9BX69 | |
| KAKAKTYEFRSDSAR | 86 | Q9HC52 | |
| SKFKTKVRRLYDIAN | 326 | Q96AV8 | |
| KYDSQKTFAKARNIA | 651 | Q5JSL3 | |
| SKFKTKIRRLYDIAN | 306 | A0AVK6 | |
| ENFSSAKRAKILNKY | 1041 | Q14185 | |
| KYDSQKSFAKARNIA | 651 | Q9BZ29 | |
| ENLTKFIAIKNKYAS | 356 | O95067 | |
| VKTSLKNAYSSAKRL | 6 | Q68J44 | |
| SNKYTKFKSEIQISI | 116 | Q8N960 | |
| STGFRVIKKKLYSSE | 211 | Q9NX09 | |
| VNDLAATAYKTIKTK | 746 | Q96JB2 | |
| KTGKAIKYVRDTLFT | 1111 | Q05707 | |
| RETGKISTYQKKFTI | 591 | Q68DX3 | |
| FYRRNTDAAKIVKQK | 451 | Q14435 | |
| RRSTKYKFKVIAYNS | 531 | Q9Y2H6 | |
| KNLKRSTQYKFRLTA | 536 | Q53EP0 | |
| YKKLTSKNKSNTIFS | 931 | O75417 | |
| QKERKVFEKYTTAAR | 971 | Q9HC77 | |
| KKKYVNSGTVTLLSF | 266 | Q8IYJ1 | |
| SKANYSLKIEARDKA | 896 | Q8TDW7 | |
| TSKRVYKQAVFDLTK | 2966 | Q5VT06 | |
| VLAFQKASSIVYKKE | 201 | P01730 | |
| YKATQKIAFSATRTI | 116 | P02746 | |
| QDVLKKSYSKAFTLT | 271 | P09543 | |
| RRKTSLYFSSKYNKE | 411 | O95243 | |
| AFARGAKVVLYTKKS | 456 | Q9NQ79 | |
| KYFKKALKARTTINF | 331 | A6NC97 | |
| SYFVQTLKIEKSTSK | 66 | Q9Y547 | |
| SKYFFTGSRDKKVVV | 681 | Q6IA86 | |
| TNKISQVCSLKTYKR | 1331 | Q5T890 | |
| LYAFTRQKFQKVLKS | 366 | Q99680 | |
| YIQSKKSQTKALEFV | 706 | D6RIA3 | |
| TKFTKKELQSLYRGF | 86 | Q9Y2W7 | |
| DTFIQKTKKLYIDSR | 116 | O75396 | |
| KADVKSTAFTFRSSK | 321 | Q92736 | |
| LKSNKDRDTKIFYSI | 131 | P22223 | |
| KLLEQSKRAKYFINS | 431 | O43781 | |
| FVRKNKTLSAAFKSS | 231 | Q9UNQ2 | |
| VTKLVESKSYNSKVF | 116 | Q6ZNG9 | |
| ASIAVYFAKRFKRKN | 646 | Q6UXK5 | |
| RVTVKSLDYSRKLKN | 111 | Q9UPQ0 | |
| QRFELYKKAQASLKS | 26 | Q70IA8 | |
| GTKETYFRNLKKKLT | 71 | Q8WV60 | |
| SKNKRTLFLFGVTKY | 196 | Q16557 | |
| DIQKKRFYLDVKQSS | 66 | Q9UJV8 | |
| AKERTVTFLSGKKYS | 456 | Q14995 | |
| TSTKNKRRKEYFLAV | 26 | Q2TAK8 | |
| KRKSTLYFNTQEKSA | 36 | Q92521 | |
| KTSILVFKDRDKYVS | 211 | Q9BRS2 | |
| EAVNKVIKSYAKFSA | 411 | P35998 | |
| NYRLKSLQKKASTSA | 126 | Q16594 | |
| FNRIYLQKKSEIDSK | 671 | Q5TCS8 | |
| QRKSEYFELKAKLQS | 806 | Q8IW52 | |
| RFLKSEIYKKLVNSQ | 126 | Q2M5E4 | |
| QKLSSKARKIYTDFI | 126 | P41220 | |
| ASQFESSAAKLKRKY | 76 | P23763 | |
| FKRISYAKTKTRAEV | 106 | Q9BYD3 | |
| LETALNSKAYKRSKR | 406 | P51531 | |
| LSKYDATKQKRKFSS | 221 | Q96GM5 | |
| ATKQKRKFSSFFKSL | 226 | Q96GM5 | |
| KVESSSESYKIRVAK | 236 | Q969N4 | |
| VNVTLLSKQAKFAYK | 116 | Q9BXJ8 | |
| VSKSGRFYVKLSKNK | 1536 | B5MCY1 | |
| VNRAKKYFLQTEDAK | 471 | Q9H0K6 | |
| AKKIYNEFISVQATK | 111 | P49798 | |
| SDRAKSQTEKLAKVY | 236 | Q8NCA5 | |
| ASYIQSKFEDLNKRK | 301 | P04899 | |
| QKFSQASSKILKYSF | 6 | Q5SWH9 | |
| SQYSVTDLKKIFSVK | 336 | Q5VXU9 | |
| YTSQDLKSALAKFKE | 126 | Q9H173 | |
| STVKTKRDTVKGYFL | 46 | Q8WWX8 | |
| YLSDTNTRKVYKLKS | 1251 | Q9UKZ4 | |
| TFLNSKKEIVDRKYS | 31 | Q13875 | |
| SRNKEAILYTYKLSK | 821 | O15457 | |
| KVTKSYSFDEIRKNA | 466 | P43490 | |
| RKVKRKLTYQFDSAL | 241 | Q01892 | |
| SFNSSYNVVKRLKVE | 61 | Q86XK3 | |
| SKAVILQSASVSKKY | 706 | Q9NZP6 | |
| YIKRAAATKLASAEK | 116 | Q9NRY4 | |
| KFTKSVINSKASLTY | 576 | Q9Y2L1 | |
| KLYSEQYTSSSKRKE | 931 | Q13023 | |
| DVYFRKTKAATILTK | 481 | Q15003 | |
| KEAKLYTINKFASVL | 641 | Q86XI2 | |
| SSVKNKIERFFRKIY | 136 | Q15846 | |
| VLGTQSKAFYKTARK | 176 | O15498 | |
| KRKRSKTANYLISID | 341 | O00294 | |
| KTQRAFSKYEKSAVL | 381 | Q9UJT1 | |
| FFSKASKNFSIKRSS | 366 | Q15468 | |
| TFYIKKYTLLKNSRA | 506 | Q8IU68 | |
| SNKIYFSAIAKTQKI | 926 | Q12768 | |
| VAAVVTTKYFKKRLA | 131 | O15374 | |
| TTKYFKKRLALSTAI | 136 | O15374 | |
| TKFITYRSKKLIQES | 1026 | O14776 | |
| KENSYVKKFSIVGTR | 221 | P28289 | |
| TKTNKVYDITERKSF | 121 | Q8IXW5 | |
| TRASDYSKKSNVLKL | 581 | Q9BQI7 | |
| SSLKRFDDKYTLKLT | 161 | Q15005 | |
| RSKAFNDIATYFSKK | 21 | Q7RTT4 | |
| RAVSDTKKAVKYQSK | 246 | Q16623 | |
| YSLVKNKISKSSFRE | 26 | Q96FQ6 | |
| SGYFAVFRVKLTAKK | 626 | Q92545 | |
| YSTENYSLESQKKRK | 691 | Q6ZV73 | |
| ENDSFLQRVIKTYKK | 101 | P22309 | |
| SENTFTEYKKKLAER | 411 | P02774 | |
| LKTYVRRNKSESFKT | 86 | Q9GZR1 | |
| ARAEKKVTLSYSKNL | 511 | Q9Y4E1 | |
| QTYSRSRKNKTYICK | 161 | Q8N841 | |
| SKQFNILRKARSYIK | 396 | O95427 | |
| SVRAVRKDQTSKLKY | 336 | Q96MU7 | |
| QKNRSYVISSFTELK | 566 | Q00722 | |
| KDSSKTFSAQTDKYR | 271 | Q9Y2K1 | |
| LRKKKTSDIYFVSLV | 346 | Q9H330 | |
| IKNTTQKKYRDYSKT | 1426 | Q6ZT12 | |
| VKSAYSERLKFNVAI | 26 | Q9BXA7 | |
| KALSKVDISFYTSLK | 1321 | Q86YA3 | |
| LKLSRKERSSAYSKN | 1466 | Q86YA3 | |
| FKTRKQKSSSKAEYN | 341 | Q2TB10 | |
| RLSVDYSKKSKLEFA | 156 | Q6PEY2 | |
| NSVKKKTKFVNLYTR | 141 | Q15650 | |
| NTQEKSFAYSKIVKT | 181 | Q6ZMW2 | |
| YDSTTNLKIKFNKIA | 716 | Q5SVZ6 | |
| CRTKFKSLQTSYRKV | 461 | Q8IWY8 | |
| KVTFQKAREYSVKTA | 241 | Q6PF06 | |
| ARTQKKYFAKSQSKI | 611 | O94979 | |
| KYFAKSQSKITRLIT | 616 | O94979 | |
| LSTSYIRLKQKVKAF | 601 | Q6P3X3 | |
| VKSAYSERLKFNVAV | 26 | Q96PF2 | |
| ENFRSISANEKKIKY | 526 | Q5SRH9 | |
| TAKQVASRVQKYFIK | 691 | Q8IYH5 | |
| ASRVQKYFIKLTKAG | 696 | Q8IYH5 | |
| KGTKVKSIRTQTDFY | 671 | Q9BVV6 | |
| FKSYKLDDTQASRKK | 271 | Q96FV9 | |
| TQLYAKVSNKLKSRS | 6 | P57075 | |
| YKKRKINSLSSKDFD | 206 | O95970 | |
| RSNLAKELEKYSKTS | 631 | Q9UL68 | |
| AAKASRDIASEFKYK | 2781 | P20929 | |
| IKSAKASRDIASDYK | 3751 | P20929 | |
| IFSEKKYRTKIETLN | 4141 | P20929 | |
| YRAAGKKQKSIFTSV | 5161 | P20929 |